U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07856797) titled 'A Study to Confirm Safety and Effectiveness of RADIESSE(R) Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds' on Sept. 29.

Brief Summary: The purpose of this study is to confirm the long-term safety, effectiveness, and degradation profile of RADIESSE(R) Injectable Implant for the correction of moderate to severe nasolabial folds (NLFs) in Chinese adults. Eligible participants will receive treatment with RADIESSE(R) Injectable Implant in both NLFs and may receive an optional touch-up treatment at Month 1 at investigator's discretion. Participants will be followed for up to 24 months after last treatment.

St...